For decades, the dietary landscape has been dominated by competing philosophies. Proponents of low-carbohydrate, high-fat diets—often touted for their efficacy in weight management and glycemic control—frequently clash with those who advocate for low-fat, plant-forward approaches. Yet, a persistent point of contention has remained: the unpredictable impact these diets have on Low-Density Lipoprotein (LDL) cholesterol, the "bad" cholesterol linked to heart disease.
New research presented at NUTRITION 2026, the flagship annual meeting of the American Society for Nutrition, suggests that the mystery of why one person sees their cholesterol plummet on a low-carb diet while another’s skyrockets may finally be solved. The answer lies not just in the food on the plate, but in the unique genetic architecture of the individual eating it.
The Genetic Variable: Unraveling the Discrepancies
For years, clinicians have been puzzled by the "responder" phenomenon. Two individuals following identical, strictly monitored low-carbohydrate regimens often yield vastly different blood panels. While some patients experience improvements in cardiovascular markers, a subset of the population reports a paradoxical, and sometimes concerning, rise in LDL cholesterol.
"Our findings suggest that some individuals may be more sensitive to the LDL cholesterol-raising effects of saturated fat, particularly in the context of a low-carbohydrate diet, because of their genetic background," explains Dr. Alexa Barad, a postdoctoral scholar at the Stanford University School of Medicine.
Dr. Barad’s research indicates that the interplay between saturated fat consumption and polygenic risk scores—the cumulative impact of thousands of genetic variants—is the missing link. When a diet is low in carbohydrates, it is frequently high in fats. If those fats are primarily saturated, individuals with a specific genetic predisposition appear to be biologically "primed" to elevate their LDL levels.
Chronology of the DIETFITS Study
To arrive at these conclusions, the research team leaned on data from the landmark DIETFITS (Diet Intervention Examining The Factors Interacting with Treatment Success) trial. This randomized controlled trial was originally designed to settle the debate between healthy low-carb and healthy low-fat diets.
The Original Framework
The DIETFITS trial involved more than 600 adults who were randomly assigned to follow either a healthy low-carbohydrate diet or a healthy low-fat diet for a duration of one year. The original analysis of this trial yielded a surprising result: there was no significant difference in long-term weight loss between the two groups. It suggested that, at a population level, the "best" diet was simply the one a patient could adhere to long-term.
The Genetic Re-analysis
Recognizing that the "one-size-fits-all" conclusion of the original trial might be obscuring individual success stories, Dr. Barad and her colleagues conducted a deeper dive into the data. They isolated 431 participants for whom comprehensive genetic data were available. By mapping genotype against saturated fat intake and tracking shifts in LDL cholesterol from baseline to the six-month mark, the researchers were able to observe patterns that were previously invisible.
Supporting Data: The Power of Polygenic Scores
Unlike previous studies that focused on single-gene mutations—often termed "candidate gene" studies—this research utilized a more robust, modern approach: the polygenic score.
By aggregating thousands of genetic variants from across the entire genome, the researchers created a "score" that represents an individual’s overall genetic tendency toward higher or lower LDL levels. The findings were stark. Participants who were genetically predisposed to higher LDL cholesterol were significantly more likely to experience an increase when placed on a low-carb diet.
Crucially, this increase was directly tied to saturated fat intake. Those with the highest genetic risk who consumed the highest levels of saturated fats—such as butter, fatty meats, and processed deli products—saw the most significant spikes in LDL cholesterol. Conversely, this specific relationship between genotype, saturated fat, and LDL increase was not observed in the group assigned to the low-fat diet, suggesting that the physiological stress of a low-carb, high-saturated-fat diet acts as a "trigger" for those with specific genetic vulnerabilities.
Expert Perspectives: Moving Beyond Simplified Narratives
The implications of this research are profound for the field of precision nutrition. Dr. Barad emphasizes that the public narrative surrounding diet is often dangerously reductive.
"Dietary conversations can sometimes become overly simplified," Barad stated during her presentation at NUTRITION 2026. "One person may say, ‘Low-carb diets always raise LDL cholesterol,’ while another says, ‘My LDL cholesterol did not change at all.’ Our findings suggest that both experiences can be true, depending, at least in part, on the individual’s genetic makeup."
This shift toward "precision nutrition" acknowledges that human biology is not a monolith. The industry is currently moving away from dogmatic dietary mandates toward a model where clinical outcomes are monitored individually. The research suggests that the "heterogeneity" of response is a biological reality, not a failure of dietary adherence or data collection.
Implications for Clinical Practice and Public Health
While the findings provide a breakthrough in understanding the mechanism behind cholesterol fluctuations, they also offer immediate, practical takeaways for clinicians and patients alike.
1. Monitoring Over Assumption
The most immediate takeaway is that genetic testing is not a prerequisite for safe dietary change. Because the human body’s response to diet is so highly individualized, clinicians should treat the first six months of any major dietary shift as a monitoring period. Regardless of a person’s diet, routine blood work is essential to detect if a specific regimen is having an unintended, adverse effect on cardiovascular markers.
2. The Quality of Fat Matters
For those who wish to maintain a low-carbohydrate lifestyle but are concerned about their LDL levels, the source of fat is the primary lever for intervention. Current dietary guidelines generally recommend keeping saturated fat below 10% of total daily caloric intake.
Dr. Barad suggests that "low-carb" does not have to mean "high-saturated-fat." Instead of relying on butter, beef tallow, or processed meats, individuals can pivot to unsaturated, heart-healthy fats. Sources such as:
- Extra virgin olive oil
- Avocados
- Nuts and seeds
- Fatty fish (rich in Omega-3s)
By shifting the lipid profile of a low-carb diet toward these sources, patients may mitigate the risk of an unfavorable cholesterol response, even if they possess a genetic predisposition for elevated LDL.
3. Future Directions
While these findings are compelling, the scientific community maintains a healthy degree of caution. Because the data was presented at a conference and is considered preliminary, the research awaits the rigorous, independent scrutiny of peer-reviewed publication.
Furthermore, the DIETFITS cohort—while robust—does not necessarily represent the full spectrum of human diversity. Future studies will need to determine if these genetic markers and their dietary interactions hold true across different ethnicities, age groups, and socioeconomic backgrounds.
Conclusion: A More Personalized Future
The era of universal dietary advice is coming to a close. The work of Dr. Barad and her colleagues at Stanford University serves as a vital reminder that our internal biological instructions—our genes—interact with our external environment in complex, nuanced ways.
For the millions of people who look to nutrition as a way to manage their health, this research provides a sense of empowerment. It moves the conversation from the rigid, often frustrating "one diet fits all" mentality to a more nuanced understanding: the "right" diet is one that aligns with both your goals and your specific, individual genetic blueprint. As we continue to refine our understanding of these interactions, the future of nutrition will likely look less like a set of general rules and more like a tailored, data-driven strategy for longevity.
Disclaimer: The DIETFITS trial was supported by the National Institute of Diabetes and Digestive and Kidney Diseases, the National Heart, Lung, and Blood Institute, and the Stanford Clinical and Translational Science Award. Dr. Alexa Barad was supported by the American Heart Association Postdoctoral Fellowship. Findings presented at NUTRITION 2026 are preliminary and should be interpreted as such until peer-reviewed publication is finalized.
